pharmaceutical ai-generated

Earnings

Equities

News

Markets

Movers

Trading Ideas

The company&#39;s also board also recommended a dividend of ₹40 per equity share for the year.

Dr. Reddy&#39;s Labs Q4 Results: Net Profit Climbs 36%, Revenue Up 12%

pharmaceutical drug medicine FDA

Large Cap

Legal

Dr. Reddy&#39;s has said that the allegations against it lack merit and asserted that it will vigorously defend the litigation.

Why Dr. Reddy&#39;s Lab Shares Crashed Near End Of Trading On Friday

Pharma stock

Having successfully launched several of its own brands in the domestic market last year, Dr. Reddy&#39;s is now strategically focused on leveraging inorganic opportunities to drive its next phase of growth.

This Large Cap Pharma Stock May Be Lining Up Big Acquisition, Shares Jump

Latest Earnings

Stock Analysis

Stock Movers

Deals

Gainers And Losers

IPOs

Artificial Intelligence

Technology

Web Stories

Benzinga Inspire

Dr. Reddy’s Laboratories - Latest News and breaking headlines

India Latest News

acf/widget-container

Latest News

acf/content-feed

India Google Sidebar Ad Unit

acf/google-ad-placement

Benzinga India Article Sidebar

Dr. Reddy’s Laboratories